BXN 16.7% 0.5¢ bioxyne limited

Ann: BXN Signs Collaboration Agreement with Cy Biopharma AG, page-2

  1. 1,433 Posts.
    lightbulb Created with Sketch. 87
    Took a position over the last few days and think there is some great potential here.

    Top 20 hold over 84%, cap raise out of the way and the sales pipeline looking exciting.

    The investor presentation video is quite good watching for a new comer and highlights some f the opportunities over the next 3-6 months which are key catalysts for the share price.

    The recent announcement regarding shares coming out of escrow may explain the recent supply and trade activity with 5 mill parcels coming onto market pre market. May see some further churn whilsts some of the BLS payment shares are flipped but I think some further Dr Watson news in the UK market or Australian sales may well overcome that and see the price head north again.
 
watchlist Created with Sketch. Add BXN (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
-0.001(16.7%)
Mkt cap ! $10.23M
Open High Low Value Volume
0.6¢ 0.6¢ 0.5¢ $36.10K 7.183M

Buyers (Bids)

No. Vol. Price($)
2 391556 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 1473902 5
View Market Depth
Last trade - 12.18pm 26/07/2024 (20 minute delay) ?
BXN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.